The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Consensus molecular subtypes (CMS) as prognostic and predictive biomarkers of RAS wild-type (WT) metastatic colorectal cancer (mCRC): Pooled analysis of the randomized trials FIRE-1, FIRE-3, XELAVIRI, and PanaMa.
 
Arndt Stahler
Honoraria - Amgen; Daiichi Sankyo Europe GmbH; Merck KGaA; Roche; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Novocure; Takeda
Travel, Accommodations, Expenses - Amgen; Lilly; Pfizer; Roche
 
Dominik Paul Modest
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Cor2Ed; GlaxoSmithKline; Lilly; Merck; Merck Serono; Onkowissen; Pierre Fabre; Sanofi; Seagen; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Cor2Ed; GlaxoSmithKline; Lilly; Merck Serono; Onkowissen; Pierre Fabre; Regeneron; SERVIER; Takeda
Research Funding - Amgen (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Sebastian Stintzing
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb GmbH; Daiichi Sankyo Europe GmbH; Merck KGaA; MSD; Nordic Bioscience; Pfizer; Pierre Fabre; Roche; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; CV6 Therapeutics; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Isofol Medical; Merck KGaA; MSD; Nordic Bioscience; Pierre Fabre; Roche; Seagen; SERVIER; TERUMO
Research Funding - Amgen (Inst); Merck Serono (Inst); MSD (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Swantje Held
No Relationships to Disclose
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Lothar Müller
No Relationships to Disclose
 
Ullrich Graeven
Stock and Other Ownership Interests - Biontech
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celltrion; Fujifilm; Ipsen; MSD Oncology; Novartis; Sanofi Aventis GmbH
Consulting or Advisory Role - Amgen; MSD Oncology
Research Funding - Ipsen (Inst); Macrogenics (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; GlaxoSmithKline
 
Thomas Decker
Consulting or Advisory Role - Novartis
 
Tobias Heintges
No Relationships to Disclose
 
Christoph Kahl
Travel, Accommodations, Expenses - Celgene
 
Werner Scheithauer
No Relationships to Disclose
 
Alexander Kiani
No Relationships to Disclose
 
Florian Kaiser
Consulting or Advisory Role - Astellas Pharma; Elsevier; GlaxoSmithKline; MSD; Novartis; Pierre Fabre; Sanofi; SERVIER
 
Ingo Schwaner
Honoraria - Abbvie; Celgene; Janssen
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Janssen; Lilly; Novartis; Roche Pharma AG; SERVIER
Expert Testimony - BeiGene
Travel, Accommodations, Expenses - BeiGene; Janssen; SERVIER
 
Stefan Fruehauf
No Relationships to Disclose
 
Meinolf Karthaus
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
 
Tanja Trarbach
No Relationships to Disclose
 
Frederik Klauschen
No Relationships to Disclose
 
David Horst
No Relationships to Disclose
 
Volker Heinemann
Stock and Other Ownership Interests - BioNTech SE
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Celgene; GlaxoSmithKline; Merck; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi; Seagen; SERVIER; Sirtex Medical
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Halozyme; Janssen; Merck; MSD; Nordic Bioscience; Novartis; Oncosil; Pierre Fabre; Roche; Servier/Pfizer; Sirtex Medical; TERUMO
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Merck; MSD; Nordic Bioscience